Nektar Therapeutics (NKTR)
41.17
+0.37
(+0.91%)
USD |
NASDAQ |
Oct 09, 16:00
41.16
-0.01
(-0.02%)
After-Hours: 20:00
Nektar Therapeutics Cash and Short Term Investments (Quarterly) : 684.34M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 684.34M |
| March 31, 2026 | 568.60M |
| December 31, 2025 | 245.75M |
| September 30, 2025 | 270.21M |
| June 30, 2025 | 175.90M |
| March 31, 2025 | 218.63M |
| December 31, 2024 | 255.23M |
| September 30, 2024 | 244.50M |
| June 30, 2024 | 271.24M |
| March 31, 2024 | 289.24M |
| December 31, 2023 | 303.62M |
| September 30, 2023 | 372.66M |
| June 30, 2023 | 409.43M |
| March 31, 2023 | 456.83M |
| December 31, 2022 | 504.98M |
| September 30, 2022 | 546.39M |
| June 30, 2022 | 619.32M |
| March 31, 2022 | 667.02M |
| December 31, 2021 | 733.96M |
| September 30, 2021 | 921.08M |
| June 30, 2021 | 1.000B |
| March 31, 2021 | 1.037B |
| December 31, 2020 | 1.062B |
| September 30, 2020 | 956.01M |
| June 30, 2020 | 1.038B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.346B |
| December 31, 2019 | 1.325B |
| September 30, 2019 | 1.496B |
| June 30, 2019 | 1.515B |
| March 31, 2019 | 1.389B |
| December 31, 2018 | 1.335B |
| September 30, 2018 | 1.420B |
| June 30, 2018 | 1.824B |
| March 31, 2018 | 296.66M |
| December 31, 2017 | 296.13M |
| September 30, 2017 | 352.57M |
| June 30, 2017 | 265.55M |
| March 31, 2017 | 358.52M |
| December 31, 2016 | 389.10M |
| September 30, 2016 | 253.51M |
| June 30, 2016 | 274.85M |
| March 31, 2016 | 288.32M |
| December 31, 2015 | 308.94M |
| September 30, 2015 | 267.82M |
| June 30, 2015 | 279.66M |
| March 31, 2015 | 325.80M |
| December 31, 2014 | 262.82M |
| September 30, 2014 | 261.64M |
| June 30, 2014 | 276.44M |
| March 31, 2014 | 284.07M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.95B |
| Inovio Pharmaceuticals, Inc. | 36.67M |
| Tonix Pharmaceuticals Holding Corp. | 176.23M |
| Capricor Therapeutics, Inc. | 237.93M |
| Kyntra Bio, Inc. | 91.32M |